Introduction
Polycystic ovary syndrome (PCOS) is a multifactorial endocrine-metabolic disorder characterized by hyperandrogenism, insulin resistance, chronic low-grade inflammation, and psychosocial stress. Emerging integrative approaches have highlighted the role of adaptogenic herbs in modulating neuroendocrine and metabolic dysfunctions associated with PCOS. Among these, Ashwagandha (Withania somnifera), a cornerstone herb in Ayurvedic medicine for over 2500 years, has gained scientific attention for its wide-ranging pharmacological properties and potential relevance in PCOS management.1
Traditional and pharmacological profile of Ashwagandha
Ashwagandha, also known as Indian ginseng, is widely recognized in Ayurvedic practice for its Rasayana (rejuvenating) properties. It has been traditionally used to enhance vitality, improve resilience to stress, and restore physiological balance. Modern pharmacological investigations have validated its diverse therapeutic actions, including antistress, antioxidant, anti-inflammatory, antibacterial, and immunomodulatory effects.
The bioactive constituents primarily responsible for these effects are steroidal lactones known as withanolides. These compounds exert pleiotropic actions on neuroendocrine, immune, and metabolic pathways, making Ashwagandha particularly relevant in stress-associated endocrine disorders such as PCOS.
Mechanisms relevant to PCOS pathophysiology
PCOS is strongly influenced by dysregulation of the hypothalamic–pituitary–adrenal (HPA) axis, insulin resistance, and chronic inflammation. Ashwagandha has demonstrated the ability to modulate stress response pathways by influencing cortisol dynamics and enhancing stress tolerance.
Experimental studies have shown that Ashwagandha increases the body’s capacity to withstand stress and improves adaptive responses while modulating circulating glucocorticoid levels. By regulating cortisol and related steroid intermediates, it may help correct stress-driven hormonal imbalance, a key contributor to ovarian dysfunction in PCOS.
Furthermore, Ashwagandha has demonstrated significant improvement in insulin sensitivity and glycemic control in experimental diabetic models, including non-insulin-dependent streptozotocin-induced diabetes. This metabolic regulatory effect is particularly relevant in PCOS, where insulin resistance plays a central pathogenic role.
Endocrine and metabolic benefits
Clinical and experimental observations suggest that Ashwagandha may help restore endocrine equilibrium by reducing excessive stress-mediated steroidogenesis.
- In one reported observation, standardized root extract administration (400 mg twice daily) resulted in reduced stress-related hormonal markers, including corticosterone, cortisol, and 11-deoxycortisol, along with other steroid intermediates. Although this report was not exclusively in a classical PCOS cohort, it highlights the herb’s ability to modulate adrenal steroid pathways that are often dysregulated in PCOS patients.
- In addition, Ashwagandha has been associated with improvements in fatigue reduction, psychological well-being, and overall metabolic balance, which indirectly supports better reproductive function in affected individuals.
Clinical observations and emerging evidence
Limited but suggestive clinical observations indicate potential benefits of Ashwagandha supplementation in stress-associated endocrine dysfunctions. Its adaptogenic activity helps regulate the HPA axis, which may indirectly influence gonadal steroid balance, ovulatory function, and metabolic stability.
In a documented case scenario, supplementation led to significant improvement in stress-related symptoms and normalization of biochemical stress markers within a short duration, supporting its potential role in neuroendocrine modulation.
Integrative role in PCOS management
Given its combined effects on stress reduction, insulin sensitivity, and hormonal modulation, Ashwagandha may serve as an adjunctive therapy in PCOS management. Its antioxidative and anti-inflammatory properties further contribute to improving the chronic inflammatory milieu associated with the disorder.
When integrated into a holistic management plan—alongside dietary regulation, lifestyle modification, and other Ayurvedic interventions—Ashwagandha may support restoration of metabolic and reproductive homeostasis.
Conclusion
Ashwagandha (Withania somnifera) represents a promising adaptogenic herb with multifaceted therapeutic potential in PCOS. Through modulation of stress pathways, improvement of insulin sensitivity, and regulation of endocrine function, it addresses several key pathological mechanisms underlying the syndrome. Although preliminary evidence is encouraging, larger controlled clinical studies are required to establish standardized dosing, efficacy, and long-term safety in PCOS populations.2
References:
- Namysł M, Matczak S, Dachowska S, et al. Withania somnifera in Women's Hormonal Modulation: A Narrative Review With Implications for Polycystic Ovary Syndrome and Premenstrual Syndrome. Cureus. 2026;18(1):e101431. Published 2026 Jan 13. doi:10.7759/cureus.101431 https://pmc.ncbi.nlm.nih.gov/articles/PMC12895992/
- Wani R, Shaikh M. Healing with Herbs: A Systematic Review of Natural Treatments for Polycystic Ovary Syndrome. JBRA Assist Reprod. 2025;29(2):359-366. Published 2025 Jul 30. doi:10.5935/1518-0557.20240110 https://pmc.ncbi.nlm.nih.gov/articles/PMC12225173/#sec7